Combined Bezafibrate and Medroxyprogesterone Acetate: Potential Novel Therapy for Acute Myeloid Leukaemia

相似書籍

• Metabolomic Profiling of Drug Responses in Acute Myeloid Leukaemia Cell Lines
  由: Tiziani, Stefano, et al.
  出版: (2009)
• Correction: Metabolomic Profiling of Drug Responses in Acute Myeloid Leukaemia Cell Lines
  由: Tiziani, Stefano, et al.
  出版: (2009)
• Single arm phase II trial assessing the safety, compliance with and activity of Bezafibrate and medroxyProgesterone acetate (BaP) therapy against myeloid and lymphoid cancers
  由: Murray, Jim, et al.
  出版: (2019)
• Hypoxia Triggers Major Metabolic Changes in AML Cells without Altering Indomethacin-Induced TCA Cycle Deregulation
  由: Lodi, Alessia, et al.
  出版: (2010)
• Lycorine sensitizes CD40 ligand-protected chronic lymphocytic leukemia cells to bezafibrate- and medroxyprogesterone acetate-induced apoptosis but dasatanib does not overcome reported CD40-mediated drug resistance
  由: Hayden, Rachel E., et al.
  出版: (2010)